Reem Almahasnah

Reem Almahasnah

Auto-generated profile, based on publicly available information

Reem Almahasnah

Department of Clinical and Pharmacy Practice, School of Clinical Pharmacy, University of Dammam, Dammam 31952, Saudi Arabia

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2017 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
FAFaten Alhomoud
Faten Alhomoud
ZAZainab Aljamea
Zainab Aljamea
RAReem Almahasnah
Reem Almahasnah
KAKhawlah Alkhalifah
Khawlah Alkhalifah
LBLama Basalelah
Lama Basalelah
FAFarah Kais Alhomoud
Farah Kais Alhomoud
There has been no review on the prevalence, possible causes, and clinical outcomes of self-medication with antibiotics (SMA) in the Middle East. Databases were searched (January 2000 through June 2016) for articles on SMA among adults aged ≥18 years living in the Middle East. A hand search for relevant citations and key journals was also performed. Twenty-two studies were found. The prevalence of SMA ranged from 19% to 82%. Age, sex, and educational and income levels were the main determinants of SMA. Socio-cultural, economic, and regulatory factors were the most commonly cited reasons for SMA. Penicillins were the antibiotics most commonly used; the antibiotics were obtained mainly via stored leftover drugs, pharmacies without prescriptions, and friends/relatives. SMA was mainly for upper respiratory tract problems. The primary sources of drug information included relatives/friends and previous successful experience. Inappropriate drug use such as wrong indication, short and long duration of treatment, sharing of antibiotics, and storing antibiotics at home for use at a later time were reported. Negative and positive outcomes of SMA were identified. It is important to understand the links between different factors promoting SMA and to assess the changing trends in order to derive strategies aimed at reducing drug-related health risks.